engleski

The Outcome of Breast Augmentation using Local Infiltration Anesthesia (LIA)

Local infiltration anesthesia (LIA) technique to obtain regional anesthesia and vasoconstriction of the skin and subcutaneous tissues is routinely adopted for primary subglandular breast augmentation. This series evaluates advantages and disadvantages of LIA in elective augmentation breast surgery as well as patients' response to this procedure. 60 patients underwent bilateral primary breast augmentation under preoperative LIA, combinations of 5 ml 0.5% levobupivacaine and 4 ml 2% lidocaine with epinephrine on each side and compared to only Ketolorac groups respectively. Midazolam 0.05 mg/kg IV were given as premedication. Surgery was performed under sevoflurane anesthesia. Postoperative pain was assessed by visual analogue scale(VAS) treating with Ketolorac and Tramadol. 60 patients were included in the LIA and only Ketorolac groups respectively. Postoperative pain was lower at 2 and 4 hour after surgery in theLIA group. Recovery room time 1 to 2 in 76, 6% vs 4-6 in Ketorolac group of patients. Vomiting were found in aaveraged 125 minutes. VAS in LIA group weretotal of 9 (5.3%) patients without complications such as hematoma or seroma formation. 86, 7% of patients discharge same day. Single shot infiltration with levobupivacaine improves postoperative pain control after breast surgery. Perioperative physicians should consider delivering LIA earlier during the procedure as opposed to solely at the time of wound closure.

breast ; augmentation ; local infiltration ; anaesthesia

nije evidentirano